Delaware Chapter of the American College of Cardiology

Join us for the ACC Delaware Chapter Meeting: ACC by the Sea for engaging live education sessions from local, regional, and national experts with Q&A real-time. The educational meeting includes topics of cardio obstetrics, lipids, amyloid, etc., and a chapter update from our Governor Dr. Vinay Hosmane. Participation in this event will earn CME/CNE/and MOC. We look forward to seeing you (IN-PERSON) September 25 - 26, 2026!

For more Information and Register: Delaware ACC By the Sea: 2026 Chapter Meeting

Download the Brochure: Brochure

Delaware Chapter of the American College of Cardiology

Our purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments.

ACC Live Courses

For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

Latest in Cardiology from ACC.org

AI-Enabled CCTA Reveals Premature Plaque Burden in South Asians
South Asians (SA) in the United States carry a higher burden of atherosclerotic cardiovascular disease (ASCVD) than other ethnic groups, and standard risk prediction tools often fail to capture this elevated risk.
ACCEL Lite: The Case For Medically Tailored Meals
In this interview, Matthew W. Martinez MD, FACC and Laurence S. Sperling, MD, FACC discuss â€œPrescribing Meals, Not Just Meds: The Case For Medically Tailored Mealsâ€.
FDA Update: Agency Approves First Oral PCSK9 Inhibitor to Treat High Cholesterol
The U.S. Food and Drug Administration (FDA) has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, to lower LDL cholesterol in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH).
API-CAT Analysis: Recurrent VTE Uncommon, Associated With Poor Short-Term Survival
Recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival among patients with cancer-associated thrombosis on extended apixaban therapy after at least six months of anticoagulation treatment, according to a post-hoc analysis of the API-CAT trial published July 13 in Circulation.
Protein Intake and Cardiovascular Health: Separating Signal From Noise
Media attention to protein has increased and resulted in significant scrutiny. Many individuals are unsure of how much protein to consume and whether higher intakes, like those recommended for exercise, are safe for cardiovascular health.